Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$536K Sell
22,998
-267
-1% -$6.83K 0.06% 251
2024
Q4
$668K Buy
23,265
+367
+2% +$11K 0.06% 219
2024
Q3
$680K Sell
22,898
-920
-4% -$28.6K 0.07% 204
2024
Q2
$803K Buy
23,818
+322
+1% +$11.1K 0.1% 151
2024
Q1
$849K Buy
23,496
+1,762
+8% +$61K 0.11% 152
2023
Q4
$710K Sell
21,734
-3
-0% -$93 0.09% 167
2023
Q3
$707K Buy
21,737
+1,087
+5% +$34.8K 0.11% 150
2023
Q2
$604K Buy
20,650
+948
+5% +$26.1K 0.09% 156
2023
Q1
$552K Buy
19,702
+1,422
+8% +$40.1K 0.1% 144
2022
Q4
$498K Buy
18,280
+5,582
+44% +$149K 0.09% 144
2022
Q3
$303K Buy
12,698
+3,052
+32% +$83.8K 0.07% 173
2022
Q2
$270K Buy
+9,646
New +$281K 0.06% 179

Other funds holding GNTX

Legacy Advisors's GNTX Position: Q1 2025 in Review

Legacy Advisors reduced its Gentex (GNTX) stake by 1.1% in Q1 2025, selling an estimated $6.83K and leaving 22,998 shares worth $536K. The position accounts for 0.06% of the portfolio, ranked #251.

Legacy Advisors first reported a position in GNTX in Q2 2022 and has held it in 12 quarters since. The position peaked at $849K in Q1 2024. 518 funds tracked by Wall St. Rank hold GNTX as of Q1 2025.

  • Legacy Advisors held 22,998 shares of Gentex worth $536K as of Q1 2025.
  • Legacy Advisors sold 267 Gentex shares in Q1 2025, an estimated $6.83K.
  • Gentex made up 0.06% of Legacy Advisors's portfolio in Q1 2025, its #251 holding.
  • Legacy Advisors first reported a position in Gentex in Q2 2022 and has held it in 12 quarters since.
  • Legacy Advisors's Gentex position peaked at $849K in Q1 2024.
  • 518 funds tracked by Wall St. Rank held Gentex as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.